Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phentermine/Topiramate in Hypothalamic Obesity
NCT06299891Phase 2Active, not recruiting
- Sponsor
- Seattle Children's
- Start
- Mar 2025
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of phentermine + topiramate in hypothalamic obesity (HO), sponsored by Seattle Children's. Started Mar 2025; status: active, not recruiting.
02
Drugs
phentermine + topiramate
03
Conditions
hypothalamic obesity (HO)
Beyond the preview
Go deeper on NCT06299891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06299891.